目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Neuralgia Treatment Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis

Chapter 4. Neuralgia Treatment Market: Treatment Business Analysis
4.1. Treatment Market Share, 2024 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Drug Based
4.4.1. Drug based market, 2018 - 2030 (USD Million)
4.4.2. Anticonvulsant medicines
4.4.2.1. Anticonvulsant medicines market, 2018 - 2030 (USD Million)
4.4.3. Tricyclic antidepressants
4.4.3.1. Tricyclic antidepressants market, 2018 - 2030 (USD Million)
4.5. Surgery
4.5.1. Surgery market, 2018 - 2030 (USD Million)
4.5.2. Radiofrequency Thermal Lesioning
4.5.2.1. Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
4.5.3. Stereotactic Radiosurgery
4.5.3.1. Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
4.5.4. Microvascular Decompression
4.5.4.1. Microvascular decompression market, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Neuralgia Treatment Market: End Use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospital & Clinics
5.4.1. Hospital & clinics market, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgery Centers
5.5.1. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neuralgia Treatment Market: Country Estimates & Trend Analysis by Product and Technology
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Russia
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Russia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Denmark neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Sweden neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.10. Norway
6.5.10.1. Key country dynamic
6.5.10.2. Regulatory framework
6.5.10.3. Competitive insights
6.5.10.4. Norway neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Thailand neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. South Korea
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. South Korea neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. GSK plc.
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Pfizer Inc.
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Novartis AG
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Biogen
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Zydus Group (Cadila Healthcare Limited)
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. H. Lundbeck A/S
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives

List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global neuralgia treatment market, by region, 2018 - 2030 (USD Million)
Table 4. Global neuralgia treatment market, by product, 2018 - 2030 (USD Million)
Table 5. Global neuralgia treatment market, by application, 2018 - 2030 (USD Million)
Table 6. Global neuralgia treatment market, by portability, 2018 - 2030 (USD Million)
Table 7. Global neuralgia treatment market, by type, 2018 - 2030 (USD Million)
Table 8. Global neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 9. North America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
Table 10. North America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 11. North America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 12. U.S. neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 13. U.S. Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 14. Canada neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 15. Canada neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 16. Mexico neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 17. Mexico neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 18. Europe neuralgia treatment market, by country, 2018 - 2030 (USD Million)
Table 19. Europe neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 20. Europe neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 21. UK neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 22. UK Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 23. Germany neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 24. Germany neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 25. France neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 26. France Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 27. Italy neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 28. Italy neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 29. Spain neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 30. Spain neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 31. Russia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 32. Russia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 33. Denmark neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 34. Denmark neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 35. Sweden neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 36. Sweden neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 37. Norway neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 38. Norway Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 39. Asia Pacific neuralgia treatment market, by country, 2018 - 2030 (USD Million)
Table 40. Asia Pacific neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 41. Asia Pacific neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 42. Japan neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 43. Japan neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 44. China neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 45. China neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 46. India neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 47. India neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 48. Australia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 49. Australia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 50. South Korea neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 51. South Korea neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 52. Thailand neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 53. Thailand neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 54. Latin America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
Table 55. Latin America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 56. Latin America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 57. Brazil neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 58. Brazil neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 59. Argentina neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 60. Argentina neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 61. Middle East & Africa Neuralgia treatment market, by country, 2018 - 2030 (USD Million)
Table 62. Middle East & Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 63. Middle East & Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 64. South Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 65. South Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 66. Saudi Arabia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 67. Saudi Arabia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 68. UAE neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 69. UAE neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
Table 70. Kuwait neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
Table 71. Kuwait neuralgia treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Neuralgia Treatment segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Treatment and end use outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Neuralgia treatment dynamics
Fig. 12 Neuralgia treatment market: Porter’s five forces analysis
Fig. 13 Neuralgia treatment market: PESTLE analysis
Fig. 14 Neuralgia treatment market: Treatment segment dashboard
Fig. 15 Neuralgia treatment market: Treatment market share analysis, 2024 & 2030
Fig. 16 Drug based market, 2018 - 2030 (USD Million)
Fig. 17 Surgery market, 2018 - 2030 (USD Million)
Fig. 18 Neuralgia treatment market: End Use segment dashboard
Fig. 19 Neuralgia treatment market: End Use market share analysis, 2024 & 2030
Fig. 20 Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
Fig. 21 Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
Fig. 22 Microvascular decompression market, 2018 - 2030 (USD Million)
Fig. 23 Others market, 2018 - 2030 (USD Million)
Fig. 24 Neuralgia treatment market revenue, by region
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 Regional marketplace: Key takeaways
Fig. 27 North America neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 28 U.S. country dynamics
Fig. 29 U.S. neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 30 Canada country dynamics
Fig. 31 Canada neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 32 Mexico country dynamics
Fig. 33 Mexico neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 34 Europe neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 35 UK country dynamics
Fig. 36 UK neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 37 Germany country dynamics
Fig. 38 Germany neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 39 France country dynamics
Fig. 40 France neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 41 Italy country dynamics
Fig. 42 Italy neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 43 Spain country dynamics
Fig. 44 Spain neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 45 Russia country dynamics
Fig. 46 Russia neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 47 Denmark country dynamics
Fig. 48 Denmark neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 49 Sweden country dynamics
Fig. 50 Sweden neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 51 Norway country dynamics
Fig. 52 Norway neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 54 Japan country dynamics
Fig. 55 Japan neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 56 China country dynamics
Fig. 57 China neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 58 India country dynamics
Fig. 59 India neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 60 Australia country dynamics
Fig. 61 Australia neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 62 Thailand country dynamics
Fig. 63 Thailand neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 64 South Korea country dynamics
Fig. 65 South Korea neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 66 Latin America neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 67 Brazil country dynamics
Fig. 68 Brazil neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 69 Argentina country dynamics
Fig. 70 Argentina neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 71 MEA neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 72 South Africa country dynamics
Fig. 73 South Africa neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia country dynamics
Fig. 75 Saudi Arabia neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 76 UAE country dynamics
Fig. 77 UAE neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 78 Kuwait Key country dynamics
Fig. 79 Kuwait neuralgia treatment market, 2018 - 2030 (USD Million)
Fig. 80 Company categorization
Fig. 81 Company market position analysis
Fig. 82 Strategic framework